ProfileGDS4718 / 213329_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 61% 60% 64% 59% 60% 62% 58% 60% 56% 63% 56% 59% 57% 60% 57% 60% 55% 62% 67% 67% 57% 57% 59% 55% 56% 70% 54% 68% 57% 60% 61% 59% 58% 60% 62% 59% 56% 59% 58% 65% 60% 63% 61% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1605861
GSM549102patient 115, normal, homogenized [OPG study]6.1078860
GSM549104patient 119, normal, homogenized [OPG study]6.4092564
GSM549108patient 138, normal, homogenized [OPG study]6.052159
GSM549119patient 077, normal, homogenized [OPG study]6.1290360
GSM549133patient 032, cancer, homogenized [OPG study]6.2433562
GSM549139patient 042, cancer, homogenized [OPG study]5.9850758
GSM549099patient 107, normal, homogenized [OPG study]6.0983160
GSM549109patient 139, normal, homogenized [OPG study]5.9094656
GSM549110patient 046, normal, homogenized [OPG study]6.3255763
GSM549114patient 063, normal, homogenized [OPG study]5.7914956
GSM549122patient 082, normal, homogenized [OPG study]6.0832259
GSM549134patient 033, cancer, homogenized [OPG study]5.8954657
GSM549136patient 036, cancer, homogenized [OPG study]6.0912760
GSM549140patient 044, cancer, homogenized [OPG study]5.9137357
GSM549111patient 047, normal, homogenized [OPG study]6.1119960
GSM549113patient 057, normal, homogenized [OPG study]5.7892155
GSM549132patient 031, cancer, homogenized [OPG study]6.230162
GSM549137patient 038, cancer, homogenized [OPG study]6.6184967
GSM549142patient 047, cancer, homogenized [OPG study]6.6274167
GSM549100patient 110, normal, homogenized [OPG study]5.9245357
GSM549107patient 135, normal, homogenized [OPG study]5.9187357
GSM549115patient 068, normal, homogenized [OPG study]6.0006959
GSM549116patient 072, normal, homogenized [OPG study]5.8295255
GSM549120patient 078, normal, homogenized [OPG study]5.8578556
GSM549131patient 030, cancer, homogenized [OPG study]6.9294170
GSM549118patient 074, normal, homogenized [OPG study]5.7210554
GSM549129patient 027, cancer, homogenized [OPG study]6.7788668
GSM549123patient 088, normal, homogenized [OPG study]5.9108557
GSM549124patient 006, cancer, homogenized [OPG study]6.1150260
GSM549126patient 015, cancer, homogenized [OPG study]6.1970961
GSM549128patient 025, cancer, homogenized [OPG study]6.0702459
GSM549103patient 117, normal, homogenized [OPG study]6.0133458
GSM549117patient 073, normal, homogenized [OPG study]6.0900960
GSM549138patient 041, cancer, homogenized [OPG study]6.2570562
GSM549141patient 045, cancer, homogenized [OPG study]6.0684859
GSM549130patient 028, cancer, homogenized [OPG study]5.8616956
GSM549101patient 111, normal, homogenized [OPG study]6.1185359
GSM549105patient 128, normal, homogenized [OPG study]5.997858
GSM549106patient 134, normal, homogenized [OPG study]6.5420365
GSM549112patient 048, normal, homogenized [OPG study]6.0822160
GSM549125patient 011, cancer, homogenized [OPG study]6.3249463
GSM549127patient 024, cancer, homogenized [OPG study]6.223261
GSM549135patient 035, cancer, homogenized [OPG study]5.90757